Table 2 Demographic and laboratory characteristics of the patients

Age, year

52 (41.5–60.0)

49.5 (28.0–56.0)

52.0 (43.2–60.0)

Gender (M:F)

92:25

22:4

70:21

%TBSA

26.0 (15.0–43.5)

57.5 (33.0–60.0)*

22.0 (12.0–31.0)

Inhalation burn (Y:N)

46:71

18:8*

28:63

Full thickness burn (Y:N)

62:54

16:10

46:44

Mode Flame/Electric/Scalding/Chemical/other

68/20/18/8/3

21/0/2/3/0

47/20/16/5/3

SAP-3 score

32.0 (27.0–38.5)

33.0 (30.0–39.0)

31.5 (25.0–37.0)

Day of ICU stay

9.0 (4.0–29.5)

26.0 (15.5–52.0)*

7.0 (3.3–20.8)

Death (Y:N)

25:93

11:16*

14:77

IG%

2.6 (0.8–5.2)

6.4 (3.1–11.6)*

1.4 (0.6–4.4)

IG count (× 10⁹/ L)

0.34 (0.07–0.85)

0.64 (0.30–2.02)*

0.21 (0.06–0.63)

WBC (× 10⁹/ L)

11.8 (7.8–15.8)

10.4 (4.5–15.2)

12.0 (8.4–16.0)

Absolute neutrophil count (× 10⁹/ L)

9.0 (5.4–12.0)

8.1 (3.8–11.7)

9.4 (5.7–12.2)

Procalcitonin (μg/L)

1.18 (0.52–4.19)

1.72 (0.69–5.47)

0.82 (0.31–4.17)

CRP (mg/L)

103.6 (41.7–173.6)

176.5 (148.6–221.8)*

77.8 (33.2–143.6)

Lactate (mmol/L)

3.3 (2.2–5.1)

4.9 (3.5–6.4)*

2.8 (2.2–4.7)

Positive blood Culture (%)

39 (33.3)

26 (100)*

13 (14.3)

Total organisms detected number (%)

65

47

18

Acinetobacter baumannii

24 (36.9)

16 (34.0)

8 (44.4)

CRAB

6 (9.2)

4 (8.5)

2 (11.1)

Pseudomonas aeruginosa

12 (18.5)

9 (19.1)

3 (16.7)

CRPA

4 (6.2)

3 (6.4)

1 (5.6)

Enterococcus spp.

5 (7.7)

4 (8.5)

1 (5.6)

Klebsiella pneumoniae

4 (6.2)

4 (8.5)

0

MRSA

3 (4.6)

2 (4.3)

1 (5.6)

Proteus mirabilis

2 (3.1)

2 (4.3)

0

Escherichia coli

2 (3.1)

1 (2.1)

1 (5.6)

Others

3 (4.6)

2 (4.3)

1 (5.6)

Antibiotics use

93 (79.5)

26 (100)

67 (73.6)